News
News
Exactech to Meet with Financial Analysts at AAOS Orthopaedic Meeting; Present Growth Strategies at Investor Conference
GAINESVILLE, Fla. – March 8, 2010 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, today announced its schedule of upcoming investor events.
Exactech Platform Fracture Stem for Shoulder Surgeries Receives FDA Clearance
GAINESVILLE, Fla. – March 2, 2010 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the company’s Equinoxe® Platform Fracture Stem, the latest addition to the company’s shoulder arthroplasty line.
Exactech 2009 Revenue Up 10% to $177M
GAINESVILLE, Fla. – February 22, 2010 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, extremities, spine and biologic materials, announced today that revenue for 2009 increased 10% to $177.3 million from $161.7 million in 2008. Diluted earnings per share for the year was $0.65 based on net income of $8.3 million. This compares with net income of $11.1 million or $0.87 diluted EPS a year ago. Net income for 2009 included pre-tax legal expenses and estimated settlement costs of $7.0 million related to the ongoing Department of Justice (DOJ) inquiry. Excluding the impact of these legal expenses, 2009 net income was $13.2 million or $1.03 diluted EPS compared with $12.7 million or $0.99 diluted EPS in 2008.
Exactech Schedules Fourth Quarter and Full Year 2009 Earnings Release and Conference Call
GAINESVILLE, Fla. – February 9, 2010 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its fourth quarter and full year 2009 financial results on Monday, February 22, 2010 after regular trading hours end. A copy of the earnings release will be available at http://www.hawkassociates.com.
Exactech to Support Orthopaedic Research and Education Through OREF Clinician Development Program
GAINESVILLE, Fla. – Jan 25, 2010 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has committed more than $100,000 to fund research and residency enhancement grants and contribute to post-graduate fellowship grants through OREF’s Clinician Development Program (CDP). Exactech has directed its support for fellowship grants to the areas of adult reconstruction, foot and ankle, and shoulder and elbow.
